FXE | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Conformer structure via JSmol |
Physical properties [] | |
---|---|
Molecular mass | 235.30 g/mol [1] |
Predicted LogP | 2.4 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C14H18FNO [1] |
IUPAC name | 2-(ethylamino)-2-(3-fluorophenyl)cyclohexan-1-one [1] |
SMILES | CCNC1(CCCCC1=O)C2=CC(=CC=C2)F [1] |
InChI | InChI=1S/C14H18FNO/c1-2-16-14(9-4-3-8-13(14)17)11-6-5-7-12(15)10-11/h5-7,10,16H,2-4,8-9H2,1H3 [1] |
InChIKey | FCETYWCLCUZFJI-UHFFFAOYSA-N [1] |
Fluorexetamine
Fluorexetamine (also known as Fluoroeticyclidinone or 2'-Oxo-3-f-pce) is a
Chemistry
Stereochemistry []
(RS)-Fluorexetamine is a racemic mixture of the optical stereoisomers
Experience reports []
There are currently 6 experience reports involving fluorexetamine on OpenErowid:
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 137332183, Fluorexetamine. Accessed June 27, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/137332183
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fluorexetamine. UNII: AN89GB52AM. Global Substance Registration System. Accessed June 27, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/AN89GB52AM